drugset / Trial / NCT02740192

Pain Control After Total Knee Arthroplasty: Benefit In Adding Single Shot Adductor Canal Block to Existing Pain Regimen Protocol?

NCT02740192

Phase 0 Completed 128 enrolled Henry Ford Health System
RandomizedParallel-groupDouble-blindTreatment

Summary

This is a randomized, double blinded, standard of care controlled clinical trial. All adult patients over eighteen desiring total knee arthroplasty will be eligible. The study compares pain control, opioid consumption, and physical exam findings in patients undergoing total knee arthroplasty between patients receiving adductor canal block and those who receiving periarticular injection alone.

Timeline

Start
2016-04
Primary completion
2016-12
Completion
2016-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Bupivacaine Other / unclassified
Background Ropivacaine Other / unclassified

Indications

No indication recorded.